In Brief: Circon
This article was originally published in The Gray Sheet
Circon: Poised to begin sales of the VaporTrode electrode and Rotating Continuous Flow Resectoscope system "in early 1995," Circon announces Jan. 9. The single-use VaporTrode, priced at $150, is designed for urological procedures and is billed as a less expensive alternative to transurethral resection of the prostate and laser vaporization, both of which are used to treat benign prostatic hyperplasia. The Rotating Continuous Flow Resectoscope, which costs about $8,000, is "ideally suited for the VaporTrode electrode," Circon says, and "reduces trauma caused by" conventional instruments...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.